Notification of Transactions of (1) Persons Discharging Managerial Responsibility and (2) Persons closely associated with Persons Discharging Managerial Responsibility

DUBLIN--()--

This form is intended for use by an issuer making a notification required by Rules 7.2 and 7.3 of the Central Bank of Ireland’s Market Abuse Rules in relation to a person falling within either of the above categories of individual. These categories are defined in Regulation 12 (8) of the Market Abuse (Directive 2003/6/EC) Regulations 2005 and are detailed as part of this form.

All relevant boxes should be completed in block capital letters.

             
1  

Name of the Issuer

 

Mainstay Medical International plc (the “Company”)

  2   Name of person discharging managerial responsibilities

Mr. Peter Crosby

3   State whether notification relates to a person closely associated with a person discharging managerial responsibilities named in 2 and identify the connected person

 

No

  4   Indicate whether the notification is in respect of a holding of the person referred to in 2 or 3 above or in respect of a non-beneficial interest

 

Notification is in respect of a grant of share options over Company Ordinary Shares to Mr. Crosby pursuant to the Company’s 2014 Share Option Plan

5   Description of shares or derivatives or other financial instruments linked to them

 

 

Share options over Company Ordinary Shares

  6   Name of registered shareholder(s) and, if more than one, number of shares or derivatives or other financial instruments linked to them, held by each shareholder

 

Mr. Peter Crosby

7   State the nature of the transaction

 

Grant of share options over Company Ordinary Shares to Mr. Crosby pursuant to the Company’s 2014 Share Option Plan

  8   Number of shares, derivatives or other financial instruments linked to them acquired

 

65,000

9   Number of shares, derivatives or other financial instruments linked to them disposed of

 

None

  10   Price per share or derivative or other financial instrument linked to them or value of transaction

 

The exercise price relating to the share options is €14.90 in accordance with the Company’s 2014 Share Option Plan

11   Date and place of transaction

 

Not applicable

  12   Date issuer informed of transaction

 

13 January 2015

13   Any additional information

 

None

  14   Name of contact and telephone number for queries

 

Tom Maher

Company Secretary

Mainstay Medical International plc

Direct: +353 1 8970257

Mobile: +353 87 8335658

   

Name and signature of duly designated officer of issuer responsible for making notification

 

Tom Maher, Company Secretary

 

______________________________________________

 

Date of notification __15 January 2015__

Short Name: Mainstay Medical Intl. PLC
Category Code: RDS
Sequence Number: 448542
Time of Receipt (offset from UTC): 20150114T181813+0000

Contacts

Mainstay Medical International plc

Contacts

Mainstay Medical International plc